333 related articles for article (PubMed ID: 34077953)
1. Activated natural killer cells predict poor clinical prognosis in high-risk B- and T-cell acute lymphoblastic leukemia.
Duault C; Kumar A; Taghi Khani A; Lee SJ; Yang L; Huang M; Hurtz C; Manning B; Ghoda L; McDonald T; Lacayo NJ; Sakamoto KM; Carroll M; Tasian SK; Marcucci G; Yu J; Caligiuri MA; Maecker HT; Swaminathan S
Blood; 2021 Oct; 138(16):1465-1480. PubMed ID: 34077953
[TBL] [Abstract][Full Text] [Related]
2. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
3. NK cells, displaying early activation, cytotoxicity and adhesion molecules, are associated with mild dengue disease.
Azeredo EL; De Oliveira-Pinto LM; Zagne SM; Cerqueira DI; Nogueira RM; Kubelka CF
Clin Exp Immunol; 2006 Feb; 143(2):345-56. PubMed ID: 16412060
[TBL] [Abstract][Full Text] [Related]
4. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
5. Impaired natural killer cell subset phenotypes in human obesity.
Bähr I; Jahn J; Zipprich A; Pahlow I; Spielmann J; Kielstein H
Immunol Res; 2018 Apr; 66(2):234-244. PubMed ID: 29560551
[TBL] [Abstract][Full Text] [Related]
6. Cytokine activation induces human memory-like NK cells.
Romee R; Schneider SE; Leong JW; Chase JM; Keppel CR; Sullivan RP; Cooper MA; Fehniger TA
Blood; 2012 Dec; 120(24):4751-60. PubMed ID: 22983442
[TBL] [Abstract][Full Text] [Related]
7. Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69
Marquardt N; Kekäläinen E; Chen P; Kvedaraite E; Wilson JN; Ivarsson MA; Mjösberg J; Berglin L; Säfholm J; Manson ML; Adner M; Al-Ameri M; Bergman P; Orre AC; Svensson M; Dahlén B; Dahlén SE; Ljunggren HG; Michaëlsson J
J Allergy Clin Immunol; 2017 Apr; 139(4):1321-1330.e4. PubMed ID: 27670241
[TBL] [Abstract][Full Text] [Related]
8. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor.
Borrego F; Robertson MJ; Ritz J; Peña J; Solana R
Immunology; 1999 May; 97(1):159-65. PubMed ID: 10447727
[TBL] [Abstract][Full Text] [Related]
9. Natural killer cell killing of acute myelogenous leukemia and acute lymphoblastic leukemia blasts by killer cell immunoglobulin-like receptor-negative natural killer cells after NKG2A and LIR-1 blockade.
Godal R; Bachanova V; Gleason M; McCullar V; Yun GH; Cooley S; Verneris MR; McGlave PB; Miller JS
Biol Blood Marrow Transplant; 2010 May; 16(5):612-21. PubMed ID: 20139023
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells.
Clausen J; Vergeiner B; Enk M; Petzer AL; Gastl G; Gunsilius E
Immunobiology; 2003; 207(2):85-93. PubMed ID: 12675266
[TBL] [Abstract][Full Text] [Related]
11. CRTAM
Ramírez-Ramírez D; Padilla-Castañeda S; Galán-Enríquez CS; Vadillo E; Prieto-Chávez JL; Jiménez-Hernández E; Vilchis-Ordóñez A; Sandoval A; Balandrán JC; Pérez-Tapia SM; Ortiz-Navarrete V; Pelayo R
J Leukoc Biol; 2019 May; 105(5):999-1013. PubMed ID: 30791148
[TBL] [Abstract][Full Text] [Related]
12. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
Dons'koi BV; Chernyshov VP; Osypchuk DV
J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity.
Satwani P; Bavishi S; Saha A; Zhao F; Ayello J; van de Ven C; Chu Y; Cairo MS
Cytotherapy; 2014 Oct; 16(10):1431-40. PubMed ID: 24856896
[TBL] [Abstract][Full Text] [Related]
14. Interferon-γ production by tubulointerstitial human CD56
Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
[TBL] [Abstract][Full Text] [Related]
15. Efficient Killing of High Risk Neuroblastoma Using Natural Killer Cells Activated by Plasmacytoid Dendritic Cells.
Cordeau M; Belounis A; Lelaidier M; Cordeiro P; Sartelet H; Herblot S; Duval M
PLoS One; 2016; 11(10):e0164401. PubMed ID: 27716850
[TBL] [Abstract][Full Text] [Related]
16. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Scott AA; Head DR; Kopecky KJ; Appelbaum FR; Theil KS; Grever MR; Chen IM; Whittaker MH; Griffith BB; Licht JD
Blood; 1994 Jul; 84(1):244-55. PubMed ID: 7517211
[TBL] [Abstract][Full Text] [Related]
17. Differential modulating effect of natural killer (NK) T cells on interferon-γ production and cytotoxic function of NK cells and its relationship with NK subsets in Chlamydia muridarum infection.
Zhao L; Gao X; Peng Y; Joyee AG; Bai H; Wang S; Yang J; Zhao W; Yang X
Immunology; 2011 Oct; 134(2):172-84. PubMed ID: 21896012
[TBL] [Abstract][Full Text] [Related]
18. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
19. The expression of killer cell inhibitory receptors on natural killer cells and activation status of CD4+ and CD8+ T cells in the decidua of normal and abnormal early pregnancies.
Chao KH; Wu MY; Chen CD; Yang JH; Yang YS; Ho HN
Hum Immunol; 1999 Sep; 60(9):791-7. PubMed ID: 10527385
[TBL] [Abstract][Full Text] [Related]
20. Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function.
Damele L; Montaldo E; Moretta L; Vitale C; Mingari MC
Front Immunol; 2018; 9():2433. PubMed ID: 30405627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]